For citations:
The FDA has approved a new drug for adolescents and adults with severe focal alopecia. Pediatric pharmacology. 2023;20(4):364. (In Russ.)
The FDA has approved a new drug for adolescents and adults with severe focal alopecia. Pediatric pharmacology. 2023;20(4):364. (In Russ.)